Press release
New Ketamine Therapy Service for Depression Launches in San Mateo, CA with 'DR. O'
Groundbreaking Depression Treatment
April 25th, 2023
New Ketamine Therapy Service for Depression Launches in San Mateo, CA with Dr. Akedemi Oguntala 'DR. O' TheTeenDoc
San Mateo, CA - Dr. Akedemi Oguntala, also known as 'DR. O' TheTeenDoc, is proud to announce the launch of a new Ketamine therapy service for depression, starting from April 1, 2023. With an estimated 8.9 million adults in the United States suffering from medication-treated Major Depressive Disorder (MDD) and 30.9% of them experiencing treatment-resistant depression (TRD), Ketamine therapy offers a much-needed solution for those who have not found relief from traditional treatment options. Dr. Oguntala's practice, based in San Mateo, CA, provides compassionate and comprehensive care for individuals struggling with mental health conditions.
Ketamine therapy has gained recognition for its fast-acting and effective results in treating various mental health conditions, including depression, anxiety, PTSD, end-of-life distress, chronic pain, drug/alcohol problems, and more. Dr. Oguntala, with her years of experience as a board-certified psychiatrist, brings a wealth of knowledge and expertise in administering Ketamine therapy in a safe and controlled environment.
"Ketamine therapy has shown great promise in helping patients with treatment-resistant depression who have not responded to other interventions," said Dr. Akedemi Oguntala, founder of the new Ketamine therapy service for depression. "With the estimated prevalence of 8.9 million adults with medication-treated MDD in the United States, and 2.8 million of them experiencing TRD, there is a critical need for innovative treatment options like Ketamine therapy to provide relief and hope for those who are struggling."
While Ketamine therapy is not typically a first-line option in treating depression, Dr. Oguntala's practice aims to provide a holistic approach to mental health care and offer innovative treatment options for those who have not found success with traditional treatments. The launch of the new Ketamine therapy service for depression in San Mateo, CA with Dr. Akedemi Oguntala 'DR. O' TheTeenDoc opens doors to new possibilities for individuals seeking relief from treatment-resistant depression and other mental health conditions.
For more information about Ketamine therapy service for depression with Dr. Akedemi Oguntala 'DR. O' TheTeenDoc, please contact:
Email: dro@theteendoc.com
Phone: 650-762-9069
TheTeenDoc
1817 Cottage Grove Avenue
San Mateo, CA
94401-3115
TheTeenDoc is a leading online platform dedicated to mental health and wellness. Founded by Dr. Adekemi Oguntala, a board-certified pediatrician and adolescent medicine specialist, TheTeenDoc aims to empower and educate teenagers as well as adults about their mental health through evidence-based information and engaging content.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New Ketamine Therapy Service for Depression Launches in San Mateo, CA with 'DR. O' here
News-ID: 3029610 • Views: …
More Releases for Ketamine
Helloinnerwell Unveils the Transformative Benefits of Ketamine for Mental Health …
Depression and anxiety remain major barriersto fulfillment for millions around the world. Traditional antidepressants may take weeks to months to have an effect, and many experience disastrous results, no results, or side effectsthat we do not want.
But a new, scientifically backed treatmentnow exists that can bring you jarred relief, potentially fast and it uses a very interesting, and run-of-the-mill drug online therapy [https://helloinnerwell.com/] of ketamine.
Compared to traditional medications, ketamine provides…
Breakthroughs in Mental Health: Calliope Health Ketamine Expands Access to Ketam …
In recent years, the landscape of mental health treatment has seen remarkable advancements, with innovative therapies offering new hope to those battling conditions like depression, anxiety, and PTSD. Among these breakthroughs, ketamine therapy has emerged as a powerful option, providing rapid relief for individuals who have not responded to traditional treatments. Calliope Health Ketamine is at the forefront of this movement, expanding access to ketamine therapy in Maryland, where it…
Ketamine treatment Market Share, Trends, Growth, Analysis and Forecast 2023-2030
The global ketamine treatment market is anticipated to grow at a CAGR of 43.7% during the forecast period (2023-2030). Ketamine has been widely used in the treatment of various conditions, including major depressive disorder, treatment-resistant depression (TRD), bipolar depression, post-traumatic stress disorder, anxiety disorders, chronic pain management, and migraine or headache management. Ketamine is also been used in the form of infusion therapy and nasal spray, and has been found…
Ketamine treatment Market 2023 Driving Factors Forecast Research 2029
Ketamine treatment market is anticipated to grow at a CAGR of 43.74% during the forecast period (2023-2030). The market's growth is attributed to prevalence of treatment-resistant depression. A considerable number of individuals with MDD do not respond to standard therapies, resulting in a patient group known as TRD. This population has a significant unmet medical need. Ketamine's ability to bring relief to TRD sufferers has resulted in its increased use…
Ketamine treatment Market 2023 Driving Factors Forecast Research 2029
Ketamine treatment market is anticipated to grow at a CAGR of 43.74% during the forecast period (2023-2030). The market's growth is attributed to prevalence of treatment-resistant depression. A considerable number of individuals with MDD do not respond to standard therapies, resulting in a patient group known as TRD. This population has a significant unmet medical need. Ketamine's ability to bring relief to TRD sufferers has resulted in its increased use…
Ketamine Treatment Market to Witness Astonishing Growth by 2029
The global ketamine treatment market is anticipated to grow at a CAGR of 43.7% during the forecast period (2023-2030). Ketamine has been widely used in the treatment of various conditions, including major depressive disorder, treatment-resistant depression (TRD), bipolar depression, post-traumatic stress disorder, anxiety disorders, chronic pain management, and migraine or headache management. Ketamine is also been used in the form of infusion therapy and nasal spray, and has been found…
